This is a Phase 2 study to evaluate the safety and efficacy of IW-1973 in patients with type 2 diabetes mellitus with albuminuria who are on a stable regimen of renin-angiotensin system inhibitors. Visit https://clinicaltrials.gov/ct2/show/NCT03217591?term=C1973-203&rank=1 for more information.
1300 W. Jefferson Street, Suite C, Franklin, IN 46131
Type 2 Diabetes Mellitus
This is a Phase 3 study to evaluate the effect of Efpeglenatide on cardiovascular outcomes in type 2 diabetes patients at high cardiovascular risk. Visit https://clinicaltrials.gov/ct2/show/NCT03496298?term=EFC14828&rank=1 for more information.
1919 State Street, Suite 440, New Albany, IN 47150